On September 24, 2018 CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in upcoming investor conferences, including the 2018 Cantor Global Healthcare Conference, the LEERINK Partners Roundtable Series: Rare Disease & Oncology, and the ROTH Battle of the NASH Thrones Investor Conference (Press release, CymaBay Therapeutics, SEP 24, 2018, View Source [SID1234529535]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2018 Cantor Global Healthcare Conference
Date: Monday, October 1
Time: 8:55am Eastern Time
Location: Intercontinental Barclay New York Hotel
Webcast: View Source

LEERINK Partners Roundtable Series: Rare Disease & Oncology
Date: Tuesday, October 2
Time: 8:30am Eastern Time
Location: Lotte New York Palace Hotel
Webcast: View Source

ROTH Battle of the NASH Thrones Investor Conference
Date: Wednesday, October 17
Time: Panel discussions and 1-on-1 meetings
Location: Park Hyatt New York Hotel